MJBizDaily

Latest Posts

, Home

Proposed law in North Macedonia to allow cannabis flower export shelved

A North Macedonian draft bill that proposed modifications to the current medical cannabis framework has been removed from parliament’s agenda, according to Telma Television. The bill would have created a legal…

News November 13
, Home

California Marijuana Notebook: Emerald Triangle growers show confidence in market health but prep for challenges ahead

After a turbulent transition into a legal market in 2018, marijuana cultivators and other cannabis companies in California's famed Emerald Triangle are finally finding their footing and are optimistic about…

News November 13
, Home

Massachusetts keeps cannabis vape ban, orders quarantine of products as regulators focus on suspect additive

Massachusetts regulators maintained a ban on the sale of cannabis oil vaporizers and devices after ordering marijuana retailers to quarantine the products on Tuesday, dealing a financial blow to MJ companies hoping…

News November 12
, Home

Canadian, overseas medical cannabis sales drive Tilray’s revenue higher

British Columbia-based cannabis producer Tilray reported third-quarter revenue of $51.1 million (CA$67.8 million), a 408% jump from the same period a year earlier. Tilray also booked an 11% improvement from…

News November 12
, Home

Cannabis comp tables – now with EV/EBITDA – as of Nov. 11, 2019

This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.

News November 12

Missouri marijuana competition

News November 12
Image of Toronto Stock Exchange building

Canadian cannabis firms rapped over ‘deficient’ corporate governance disclosures

Canada’s securities watchdog is warning the nation’s cannabis businesses of “deficient” corporate governance disclosures and urging them to address concerns related to potential conflicts of interest. The Canadian Securities Administrators…

News November 12
, Home

New UK guidelines recommend public insurance coverage for two GW Pharma cannabis medicines, plus a synthetic cannabinoid

New British guidelines for the first time recommend that two plant-based cannabis medicines – Sativex and Epidiolex – be covered through the United Kingdom’s National Health Service (NHS), a significant…

News November 12
, Home

Cronos to convert some cultivation space, reports revenue growth

Ontario-based Cronos Group reported quarterly revenue of 12.7 million Canadian dollars ($9.6 million), an improvement over the previous quarter’s CA$10.2 million but slightly lower than consensus estimates. The cannabinoid company’s…

News November 12
MJBizCon Logo